CommentTrials and tribulations on the path to remyelination
Reference (10)
- et al.
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
Lancet Neurol
(2021) - et al.
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
Lancet
(2017) - et al.
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
Lancet Neurol
(2017) - et al.
Regenerating CNS myelin—from mechanisms to experimental medicines
Nat Rev Neurosci
(2017) - et al.
Retinoid X receptor gamma signaling accelerates CNS remyelination
Nat Neurosci
(2011)
There are more references available in the full text version of this article.
Cited by (1)
Impact of the Voltage-Gated Calcium Channel Antagonist Nimodipine on the Development of Oligodendrocyte Precursor Cells
2023, International Journal of Molecular Sciences
© 2021 Elsevier Ltd. All rights reserved.